Ning Wang, PhD

Research Fellow

Education and Training
Peking University (China), BS, Chemistry
University of Alabama at Birmingham (USA), PhD, Pathology

Positions and Honors
Positions and Employment
2006- present: Research Fellow, Vincent Center for Reproductive Biology,
                         Vincent Obstetrics & Gynecology Service, Massachusetts General 
                         Hospital, Harvard Medical School, Boston, MA

Professional Memberships
2006-present:  Member, American Socitety for Bone & Mineral Research (ASBMR)
2006-present:  Member, Sigma Xi 
  
Honors:
2005:          First place - John R. Durant Award for Excellence in Cancer Research, Comprehensive 
                   Cancer Center, University of Alabama/Birmingham School of Medicine
2000-2002: National Institutes of Health (NIH) Fellowships 
  

Selected peer-reviewed publications

1) Wan M, Cao X, Wu Y, Bai S, Wu L, Shi X, Wang N, Cao X. Jab1 Antagonizes TGF-ß Signaling by Inducing Smad4 Degradation. EMBO Rep. 2002; 3: 171-6.

2) Li Q, Wu L, Oelschlager DK, Wan M, Stockard CR, Grizzle WE, Wang N, Chen H, Sun Y, Cao X. Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor a Positive Breast Cancer Cells. J Biol Chem. 2005; 280: 27022-8

3) Wan M, Huang J, Jhala NC, Tytler EM, Yang L, Vickers SM, Tang Y, Lu C, Wang N, Cao X. SCFß-TrCP1 Controls Smad4 Protein Stability in Pancreatic Cancer Cells. Am J Pathol. 2005; 166: 1379-92.

4) Wang N, Kim H, Cotta CV, Wan M, Tang Y, Klug CA, Cao X. TGFß/BMP Inhibits the Bone Marrow Transformation Capability of Hoxa9 by Repressing Its DNA-binding Ability. EMBO Journal. 2006; 25: 1469-80

5) Yang L*, Wang N*, Cao, X., Wan, M. Acute Myelogenous Leukemia-Derived Smad4 Mutations Target the Protein to Ubiquitin-Proteosome Degradation. (In press, Hum Mutation, *contribute equally)